This Symposium is designed for physicians and researchers interested in the prevention, screening, evaluation, and management of genitourinary cancers, including medical oncologists; urologists; radiation oncologists; radiologists; pathologists; epidemiologists, pharmacologists; and translational-oriented laboratory scientists.

This Symposium may also be of benefit to nurses, pharmacists, physician assistants, and other health care professionals involved in clinical care and research in this area.

Learning Objectives

• Upon participation in this activity, attendees will be able to
• Analyze treatment options to individualize care for patients
• Evaluate diagnostic dilemmas for rare tumors and assess current treatment options and promising novel targets in initial stages of development
• Select the molecular imaging, adjuvant, and neoadjuvant therapeutic strategies to effectively manage and treat patients
• Interpret appropriate sequencing of treatment for patients with genitourinary cancers, based on imaging results, current surgical standards, and the predicted patient response to immunotherapy
• Appraise the use of molecular biomarkers and gene-expression data in genitourinary cancers to determine treatment options based on varying disease progression
• Determine when active surveillance provides a viable alternative to treatment based on the best available data and counsel patients regarding this approach when appropriate